Hans Peter Hasler - Articles and news items

Elan logo

Elan announces transactions: decisively transforming the company

Industry news, News / 20 May 2013 / Elan Corporation

Elan Corporation announces a series of transactions designed to decisively transform and advance the company…

Biogen Idec logo

Biogen Idec and Elan submit applications for first-line use of TYSABRI in anti-JCV antibody negative patients with MS

Industry news, News / 16 January 2013 / Biogen Idec

Biogen Idec and Elan have submitted applications to the U.S. FDA…

Biogen Idec logo

TYSABRI® (natalizumab) Data at ECTRIMS Reaffirm Positive Effects of Treatment for People with Relapsing Forms of MS

Industry news, News / 11 October 2012 / Biogen Idec

Results from 11 company-sponsored TYSABRI presentations…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+